Home : Health : Healthy Living :
Large Map
  • Healthy Living
Health group didn't disclose HIV tests, apologizes
Health group didn't disclose HIV tests

Kaiser Permanente Northwest is apologizing to nearly 6,500 …

Ostomy saved me from a life in the bathroom
Ostomy saved me from a life in bathroom

Doug Yakich had a life-changing colostomy about two years ago. …

Another round for the House on 'Obamacare'
Another round for the House on ACA

Only months away from the rollout of coverage for uninsured …

Study: Malaria-infected mosquitoes more attracted to human odor
Malaria, mosquitoes and human odor

Scientists are exploring how the malaria parasite itself may …

Health care workers sickened by new virus
New virus sickens health care workers

The health care workers were exposed to patients with the novel…

Advertisement

NY bio co. gets $4.6M from Russia to develop drugs

Initiative focuses on anti-infection drugs

Updated: Wednesday, 28 Nov 2012, 3:35 PM CST
Published : Wednesday, 28 Nov 2012, 3:35 PM CST

  • The Associated Press

BUFFALO, N.Y. (AP) - A western New York company says it has signed a $4.6 million contract with Russia to develop anti-infection drugs.

Buffalo-based Cleveland BioLabs Inc. says the contract with the Ministry of Industry and Trade of the Russian Federation was issued under the federation's "Pharma 2020" pharmaceutical development initiative.

The contract announced Tuesday focuses on Xenomycins, a family of compounds being developed as potential treatments for infectious diseases. It's being handled through Panacela Labs, a biotechnology startup company that was founded last year as a joint venture between Cleveland BioLabs and a Russian investment company.

 

Advertisement
Advertisement